论文部分内容阅读
全身用糖皮质激素可在短期内改善早产儿的呼吸功能,减少婴儿支气管肺发育不良(BPD) 的发病率,但是由此带来的中枢神经系统的远期不良反应,限制了其在临床上的广泛应用。本文回顾现有文献资料,为如何合理使用糖皮质激素治疗婴儿BPD提供指导。
Systemic glucocorticoids improve respiratory function in preterm infants in the short term and reduce the incidence of bronchopulmonary dysplasia (BPD) in infancy, but the resulting long-term central nervous system adverse effects limit their clinical utility The wide range of applications. This article reviews existing literature and provides guidance for rational use of glucocorticoid in the treatment of infantile BPD.